Improving Clinical Decision Making with Engaging CME, Tools, & Resources
GLP-1 Use and AMD Risk
Barton Lynn Blackorby, MD
Katharine Talcott, MD
Hong-Uyen Hua, MD
MH Risk Factors After RRD Repair
Maria H. Berrocal, MD
Avni P. Finn, MD, MBA
Retinal Vein Occlusion: The Case for Prompt Treatment
Ashkan Abbey, MD
Outcomes for PDR Patients LTFU for at Least 1 Year
Kyle Davis Kovacs, MD
Matt Starr, MD
Nita Valikodath, MD, MS
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
Diagnosis Delays in Stargardt Disease
Alexis Warren, MD
Jesse Sengillo, MD
Sruthi Arepalli, MD
Practice Efficiency and Innovation
Jacob Lang
Elevating Clinical Efficiency
Diana Chu
EMPOWER - Cornea Health Diagnostic Tools
Jacob Lang, OD, FAAO
Paul Hammond, OD, FAAO
Jason E. Compton, OD, FAAO
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Lisa Schocket, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.